Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor SensitivityIlirjana Bajrami, Alan Ashworth, Farah Rehman et al.|Cancer Research|2013Cited by 367
Large-Scale Profiling of Kinase Dependencies in Cancer Cell LinesJames Campbell, Christopher J. Lord, Colm J. Ryan et al.|Cell Reports|2016Cited by 109